Cargando…

Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy

BACKGROUND: The long-term outcomes of adult patients with immune thrombocytopenic purpura (ITP) after splenectomy are not clear. METHODS: We retrospectively analyzed 31 patients who underwent splenectomy after diagnosis of ITP at our institution between 1990 and 2009. Long-term follow-up was defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jae Joon, Baek, Sun Kyung, Lee, Jae Jin, Kim, Si-Young, Cho, Kyung Sam, Yoon, Hwi-Joong
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983037/
https://www.ncbi.nlm.nih.gov/pubmed/21120210
http://dx.doi.org/10.5045/kjh.2010.45.3.197
_version_ 1782191792616112128
author Han, Jae Joon
Baek, Sun Kyung
Lee, Jae Jin
Kim, Si-Young
Cho, Kyung Sam
Yoon, Hwi-Joong
author_facet Han, Jae Joon
Baek, Sun Kyung
Lee, Jae Jin
Kim, Si-Young
Cho, Kyung Sam
Yoon, Hwi-Joong
author_sort Han, Jae Joon
collection PubMed
description BACKGROUND: The long-term outcomes of adult patients with immune thrombocytopenic purpura (ITP) after splenectomy are not clear. METHODS: We retrospectively analyzed 31 patients who underwent splenectomy after diagnosis of ITP at our institution between 1990 and 2009. Long-term follow-up was defined as a follow-up that lasted 1 year or more from splenectomy to the last follow-up. RESULTS: The overall response rate to splenectomy was 84%. However, the response rate at 6 and 12 months decreased to 77% and 68%, respectively. During the 6 years of median follow-up after splenectomy, 11 patients (35%) relapsed. The long-term response rate was 55%. The long-term follow-up of 26 patients after responding to splenectomy showed that the median time from splenectomy to relapse was 19 months in the partial response (PR) group; however, there was no relapse after 9 months in the complete response (CR) group. Variables, including age, were not predictive of the long-term response after splenectomy. Additional treatment in patients who did not respond or relapsed after splenectomy was mostly effective. After a median follow-up of 7 years (range: 1-25 years) from the diagnosis, there were 2 deaths, including one due to spontaneous bleeding after repair of duodenal ulcer perforation. CONCLUSION: Although splenectomy is safe and effective, the response rate after splenectomy continuously decreases over time. The duration of response is different between the patients that achieved CR and those that achieved PR. Factors, including age, were not predictors of a response to splenectomy.
format Text
id pubmed-2983037
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-29830372010-11-30 Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy Han, Jae Joon Baek, Sun Kyung Lee, Jae Jin Kim, Si-Young Cho, Kyung Sam Yoon, Hwi-Joong Korean J Hematol Original Article BACKGROUND: The long-term outcomes of adult patients with immune thrombocytopenic purpura (ITP) after splenectomy are not clear. METHODS: We retrospectively analyzed 31 patients who underwent splenectomy after diagnosis of ITP at our institution between 1990 and 2009. Long-term follow-up was defined as a follow-up that lasted 1 year or more from splenectomy to the last follow-up. RESULTS: The overall response rate to splenectomy was 84%. However, the response rate at 6 and 12 months decreased to 77% and 68%, respectively. During the 6 years of median follow-up after splenectomy, 11 patients (35%) relapsed. The long-term response rate was 55%. The long-term follow-up of 26 patients after responding to splenectomy showed that the median time from splenectomy to relapse was 19 months in the partial response (PR) group; however, there was no relapse after 9 months in the complete response (CR) group. Variables, including age, were not predictive of the long-term response after splenectomy. Additional treatment in patients who did not respond or relapsed after splenectomy was mostly effective. After a median follow-up of 7 years (range: 1-25 years) from the diagnosis, there were 2 deaths, including one due to spontaneous bleeding after repair of duodenal ulcer perforation. CONCLUSION: Although splenectomy is safe and effective, the response rate after splenectomy continuously decreases over time. The duration of response is different between the patients that achieved CR and those that achieved PR. Factors, including age, were not predictors of a response to splenectomy. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010-09 2010-09-30 /pmc/articles/PMC2983037/ /pubmed/21120210 http://dx.doi.org/10.5045/kjh.2010.45.3.197 Text en © 2010 The Korean Journal of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Han, Jae Joon
Baek, Sun Kyung
Lee, Jae Jin
Kim, Si-Young
Cho, Kyung Sam
Yoon, Hwi-Joong
Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
title Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
title_full Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
title_fullStr Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
title_full_unstemmed Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
title_short Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
title_sort long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983037/
https://www.ncbi.nlm.nih.gov/pubmed/21120210
http://dx.doi.org/10.5045/kjh.2010.45.3.197
work_keys_str_mv AT hanjaejoon longtermoutcomesofa5yearfollowupofpatientswithimmunethrombocytopenicpurpuraaftersplenectomy
AT baeksunkyung longtermoutcomesofa5yearfollowupofpatientswithimmunethrombocytopenicpurpuraaftersplenectomy
AT leejaejin longtermoutcomesofa5yearfollowupofpatientswithimmunethrombocytopenicpurpuraaftersplenectomy
AT kimsiyoung longtermoutcomesofa5yearfollowupofpatientswithimmunethrombocytopenicpurpuraaftersplenectomy
AT chokyungsam longtermoutcomesofa5yearfollowupofpatientswithimmunethrombocytopenicpurpuraaftersplenectomy
AT yoonhwijoong longtermoutcomesofa5yearfollowupofpatientswithimmunethrombocytopenicpurpuraaftersplenectomy